Phase I clinical trial of SARS-CoV-2 neutralising monoclonal antibodies.
Latest Information Update: 27 Oct 2020
At a glance
- Drugs SARS-CoV-2 neutralising monoclonal antibodies International AIDS Vaccine Initiative/The Scripps Research Institute/Serum Institute of India/Merck (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 27 Oct 2020 New trial record
- 22 Oct 2020 According to Serum Institute of India, trial is expected to start early in 2021.